DENVER, Aug. 28 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) , a rapidly expanding International e-Health medical information technology company providing information management software products and services to the healthcare industry, has been chosen "Company of the Month" for August, 2007, by The Bowser Report newsletter. The Bowser Report is a subscription-based newsletter paid for solely by its readers. Neither research nor coverage is paid for by the companies featured in the publication. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) "The Bowser Report's (and its readers') choice is truly gratifying," said CEO Michael I. Ruxin, M.D. "It is a rewarding recognition of our rapid growth to 634 sites domestically and internationally as a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers that include such clients as Mayo Clinic, Memorial Sloan-Kettering Cancer Center, Stanford University Medical School, New York Presbyterian Hospital, Los Angeles' Cedars-Sinai Health System, and Pittsburgh's Institute for Transfusion Medicine." The Bowser Report is a monthly ten-page newsletter that recommends stocks trading at $3.00 a share or less on the NYSE, NASDAQ, AMEX and OTCBB. It is considered one of the investment community's top ten news letters. Only one "Company of the Month" is highlighted in each issue. The publication is now in its 30th year. Recently a European version of The Bowser Report was launched. Max Bowser, founder, has authored three widely read books. The third edition of "Making Dollars with Pennies," will be published later this year. About Global Med Technologies, Inc. Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the Donor Doc(TM) interactive donor health history questionnaire, SafeTrace(R) donor management system, and the SafeTrace Tx(R) advanced transfusion management system, recently patented, provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, peoplemed.com, and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies(R), Inc. CONTACT: company, Michael I. Ruxin, M.D. of Global Med Technologies, Inc., +1-303-238-2000; or investors, Paul Holm of H.L. Lanzet, +1-212-888-4570, , for Global Med Technologies(R), Inc. Web site: http://www.globalmedtech.com/ http://www.wyndgate.com/

Copyright